ONCOLYTICS BIOTECH INC's ticker is ONCYF and the CUSIP is 682310107. A total of 27 filers reported holding ONCOLYTICS BIOTECH INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $54,000 | -18.2% | 119,630 | -9.1% | 0.01% | -14.3% |
| Q2 2015 | $66,000 | -32.0% | 131,630 | 0.0% | 0.01% | -30.0% |
| Q1 2015 | $97,000 | +38.6% | 131,630 | 0.0% | 0.01% | +25.0% |
| Q4 2014 | $70,000 | -7.9% | 131,630 | 0.0% | 0.01% | -11.1% |
| Q3 2014 | $76,000 | -68.1% | 131,630 | -29.2% | 0.01% | -70.0% |
| Q2 2014 | $238,000 | -26.5% | 185,930 | +4.0% | 0.03% | -34.8% |
| Q1 2014 | $324,000 | -41.5% | 178,830 | -50.0% | 0.05% | +7.0% |
| Q4 2013 | $554,000 | +113.1% | 357,770 | +235.9% | 0.04% | -4.4% |
| Q3 2013 | $260,000 | +664.7% | 106,500 | +795.0% | 0.04% | +542.9% |
| Q2 2013 | $34,000 | – | 11,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SOPHROSYNE CAPITAL LLC | 222,900 | $345,000 | 0.30% |
| ACUITY INVESTMENT MANAGEMENT INC | 69,300 | $108,000 | 0.04% |
| VSR Financial Services, Inc. | 357,770 | $554,000 | 0.04% |
| 1832 Asset Management L.P. | 2,704,900 | $4,227,000 | 0.02% |
| Paradigm Financial Advisors, LLC | 9,558 | $15,000 | 0.02% |
| AGF INVESTMENTS INC. | 860,749 | $1,345,000 | 0.01% |
| BANK OF MONTREAL /CAN/ | 1,833,669 | $2,842,000 | 0.00% |
| BANK OF NOVA SCOTIA | 500,000 | $781,000 | 0.00% |
| RUSSELL FRANK CO/ | 1,005,900 | $1,553,000 | 0.00% |
| First Eagle Investment Management, LLC | 427,200 | $662,000 | 0.00% |